色谱 ›› 2022, Vol. 40 ›› Issue (9): 843-853.DOI: 10.3724/SP.J.1123.2021.12028
冯军军1, 姜海云2, 王静3, 景正义1, 张帆1, 谭天宇1, 贺锋1, 江利华1, 李海芹1, 常世敏1, 李腾飞1,*()
收稿日期:
2021-12-28
出版日期:
2022-09-08
发布日期:
2022-09-26
通讯作者:
李腾飞
基金资助:
FENG Junjun1, JIANG Haiyun2, WANG Jing3, JING Zhengyi1, ZHANG Fan1, TAN Tianyu1, HE Feng1, JIANG Lihua1, LI Haiqin1, CHANG Shimin1, LI Tengfei1,*()
Received:
2021-12-28
Online:
2022-09-08
Published:
2022-09-26
Contact:
LI Tengfei
Supported by:
摘要:
研究从豆芽质量安全监管的实际需求出发,建立了QuEChERS-高效液相色谱-串联质谱同时测定豆芽中植物生长调节剂、杀菌剂、杀虫剂和抗生素类等40种药物残留的方法。首先通过参数优化确定最佳质谱条件,然后比较不同提取溶剂(甲醇、乙腈、0.1%氨水乙腈、1%乙酸乙腈)、提取方法(超声、振荡)以及乙二胺-N-丙基硅烷化硅胶(PSA)、C18净化剂添加量时40种药物的回收率,确定最优前处理过程。样品用10 mL 1%乙酸乙腈提取两次,超声波辅助提取,100 mg C18为净化剂。选用Waters ACQUITY UPLC BEH C18色谱柱(100 mm×2.1 mm, 1.7 μm)进行分离,甲醇和0.01%甲酸水为流动相梯度洗脱,多反应监测(MRM)模式进行质谱监测,基质匹配外标法定量。结果表明,40种药物可在15 min内完成色谱分离,在2~200 μg/L的线性范围内均呈现出良好的线性关系,相关系数(r2)均大于0.99,检出限(LOD)和定量限(LOQ)分别为0.1~3 μg/kg和0.3~9 μg/kg。以阴性豆芽为基质,分别在5、10、50 μg/kg 3个水平下进行加标回收试验,40种药物的平均回收率为78.5%~115.3%,相对标准偏差(RSD)为1.3%~9.7%(n=6)。将该方法用于分析邯郸本地豆芽中40种药物的污染状况,结果显示4-氯苯氧乙酸、6-苄基腺嘌呤、多菌灵、2,4-二氯苯氧乙酸(2,4-D)、赤霉素和恩诺沙星检出率较高,分别为28.6%、19.0%、9.5%、9.5%、4.8%和4.8%,含量范围为37.5~352.4、32.4~273.1、28.8~38.7、16.1~20.2、19.9和13.6 μg/kg。研究建立的方法简单、快速,灵敏度高,适用于大批量豆芽中40种药物的快速准确测定。
中图分类号:
冯军军, 姜海云, 王静, 景正义, 张帆, 谭天宇, 贺锋, 江利华, 李海芹, 常世敏, 李腾飞. QuEChERS-高效液相色谱-串联质谱法同时测定豆芽中40种植物生长调节剂、杀菌剂、杀虫剂和抗生素类药物残留[J]. 色谱, 2022, 40(9): 843-853.
FENG Junjun, JIANG Haiyun, WANG Jing, JING Zhengyi, ZHANG Fan, TAN Tianyu, HE Feng, JIANG Lihua, LI Haiqin, CHANG Shimin, LI Tengfei. Simultaneous determination of 40 plant growth regulators, fungicides, insecticides, and antibiotics in bean sprouts by QuEChERS-high performance liquid chromatography-tandem mass spectrometry[J]. Chinese Journal of Chromatography, 2022, 40(9): 843-853.
No. | Compound | Retention time/min | Ionization mode | Precursor ion (m/z) | Product ions (m/z) | Collision energies/eV |
---|---|---|---|---|---|---|
1 | chlormequat (矮壮素) | 1.066 | ESI+ | 122.10 | 58.10*, 63.10 | -31, -24 |
2 | ronidazole (洛硝哒唑) | 3.903 | ESI+ | 201.00 | 139.70*, 54.60 | -10, -15 |
3 | metronidazole (甲硝唑) | 3.999 | ESI+ | 172.00 | 81.80*, 127.70 | -25, -15 |
4 | pymetrozine (吡蚜酮) | 4.192 | ESI+ | 408.10 | 105.05*, 68.10 | -39, -30 |
5 | dimetridazole (二甲硝咪唑) | 5.211 | ESI+ | 142.10 | 96.05*, 81.10 | -16, -27 |
6 | methomyl (灭多威) | 6.850 | ESI+ | 163.05 | 88.00*, 106.05 | -11, -13 |
7 | carbendazim (多菌灵) | 6.959 | ESI+ | 192.05 | 160.05*, 32.05 | -17, -30 |
8 | levofloxacin (氧氟沙星) | 7.261 | ESI+ | 362.10 | 318.20*, 61.10 | -20, -30 |
9 | enoxacin (依诺沙星) | 7.272 | ESI+ | 340.20 | 303.10*, 203.85 | -20, -48 |
10 | pefloxacin mesylate (培氟沙星) | 7.301 | ESI+ | 334.00 | 290.10*, 16.10 | -20, -20 |
11 | norfloxacin (诺氟沙星) | 7.384 | ESI+ | 320.00 | 302.00*, 76.00 | -20, -17 |
12 | ciprofloxacin (环丙沙星) | 7.537 | ESI+ | 332.20 | 314.05*, 31.00 | -24, -41 |
13 | enrofloxacin (恩诺沙星) | 7.672 | ESI+ | 360.20 | 316.10*, 42.15 | -22, -25 |
14 | thiabendazole (噻菌灵) | 7.749 | ESI+ | 202.00 | 175.05*, 31.10 | -24, -33 |
15 | lomefloxacin (洛美沙星) | 7.749 | ESI+ | 352.00 | 265.00*, 80.10 | -25, -20 |
16 | chlorpyrifos (毒死蜱) | 7.768 | ESI+ | 351.90 | 265.05*, 37.05 | -30, -39 |
17 | sarafloxacin (沙拉沙星) | 8.048 | ESI+ | 385.90 | 367.95*, 98.90 | -25, -20 |
18 | imidacloprid (吡虫啉) | 8.172 | ESI+ | 256.05 | 175.10*, 09.05 | -17, -14 |
19 | sparfloxacin (司帕沙星) | 8.480 | ESI+ | 393.00 | 349.00*, 92.00 | -40, -20 |
20 | acetamiprid (啶虫脒) | 8.682 | ESI+ | 223.10 | 126.05*, 56.05 | -22, -15 |
21 | gibberellic acid (赤霉素) | 8.744 | ESI- | 345.40 | 143.20*, 39.50 | 32, 16 |
22 | 4-fluorophenoxyacetic acid (4-氟苯氧乙酸) | 8.941 | ESI- | 169.20 | 111.00*, 95.00 | 16, 18 |
23 | chloramphenicol (氯霉素) | 9.144 | ESI- | 340.00 | 152.10*, 57.10 | 17, 11 |
24 | 3-indolylacetic acid (吲哚乙酸) | 9.230 | ESI+ | 176.10 | 129.80*, 03.10 | -18, -16 |
25 | N6-(δ2-isopentenyl)-adenine (异戊烯腺嘌呤) | 9.434 | ESI- | 202.30 | 133.00*, 34.15 | 22, 17 |
26 | 6-benzylaminopurine (6-苄基腺嘌呤) | 9.487 | ESI- | 224.00 | 133.00*, 06.00 | 40, 34 |
27 | 4-chlorophenoxyacetic acid (4-氯苯氧乙酸) | 10.040 | ESI- | 185.00 | 127.10*, 29.00 | 15, 14 |
28 | thidiazuron (噻苯隆) | 10.056 | ESI+ | 240.20 | 102.00*, 28.00 | -16, -17 |
29 | 3-indolebutyric acid (吲哚丁酸) | 10.229 | ESI+ | 204.20 | 186.20*, 29.90 | -10, -28 |
30 | atrazine (莠去津) | 10.556 | ESI+ | 406.10 | 174.05*, 96.05 | -17, -25 |
31 | forchlorfenuron (氯吡脲) | 10.595 | ESI+ | 248.05 | 129.05*, 93.05 | -17, -34 |
32 | metalaxyl-M (精甲霜灵) | 10.614 | ESI+ | 280.10 | 220.15*, 48.10 | -13, -10 |
33 | metalaxyl (甲霜灵) | 10.619 | ESI+ | 280.10 | 220.15*, 92.15 | -13, -18 |
34 | 2,4-dichlorophenoxyacetic acid (2,4-滴) | 10.669 | ESI- | 409.00 | 160.85*, 25.00 | 14, 29 |
35 | azoxystrobin (嘧菌酯) | 10.826 | ESI+ | 404.10 | 372.05*, 29.00 | -14, -31 |
36 | paclobutrazol (多效唑) | 11.064 | ESI+ | 294.10 | 70.05*, 125.05 | -40, -40 |
37 | triazophos (三唑磷) | 11.152 | ESI+ | 314.05 | 162.15*, 19.15 | -19, -35 |
38 | isazophos (氯唑磷) | 11.161 | ESI+ | 314.10 | 162.10*, 20.10 | -16, -27 |
39 | flusilazole (氟硅唑) | 11.394 | ESI+ | 316.10 | 247.10*, 65.10 | -18, -29 |
40 | pyraclostrobin (吡唑醚菌酯) | 11.635 | ESI+ | 388.10 | 194.05*, 63.05 | -30, -32 |
表 1 MRM模式下40种化合物的保留时间与质谱参数
Table 1 Retention times and MS/MS parameters for the 40 compounds in MRM mode
No. | Compound | Retention time/min | Ionization mode | Precursor ion (m/z) | Product ions (m/z) | Collision energies/eV |
---|---|---|---|---|---|---|
1 | chlormequat (矮壮素) | 1.066 | ESI+ | 122.10 | 58.10*, 63.10 | -31, -24 |
2 | ronidazole (洛硝哒唑) | 3.903 | ESI+ | 201.00 | 139.70*, 54.60 | -10, -15 |
3 | metronidazole (甲硝唑) | 3.999 | ESI+ | 172.00 | 81.80*, 127.70 | -25, -15 |
4 | pymetrozine (吡蚜酮) | 4.192 | ESI+ | 408.10 | 105.05*, 68.10 | -39, -30 |
5 | dimetridazole (二甲硝咪唑) | 5.211 | ESI+ | 142.10 | 96.05*, 81.10 | -16, -27 |
6 | methomyl (灭多威) | 6.850 | ESI+ | 163.05 | 88.00*, 106.05 | -11, -13 |
7 | carbendazim (多菌灵) | 6.959 | ESI+ | 192.05 | 160.05*, 32.05 | -17, -30 |
8 | levofloxacin (氧氟沙星) | 7.261 | ESI+ | 362.10 | 318.20*, 61.10 | -20, -30 |
9 | enoxacin (依诺沙星) | 7.272 | ESI+ | 340.20 | 303.10*, 203.85 | -20, -48 |
10 | pefloxacin mesylate (培氟沙星) | 7.301 | ESI+ | 334.00 | 290.10*, 16.10 | -20, -20 |
11 | norfloxacin (诺氟沙星) | 7.384 | ESI+ | 320.00 | 302.00*, 76.00 | -20, -17 |
12 | ciprofloxacin (环丙沙星) | 7.537 | ESI+ | 332.20 | 314.05*, 31.00 | -24, -41 |
13 | enrofloxacin (恩诺沙星) | 7.672 | ESI+ | 360.20 | 316.10*, 42.15 | -22, -25 |
14 | thiabendazole (噻菌灵) | 7.749 | ESI+ | 202.00 | 175.05*, 31.10 | -24, -33 |
15 | lomefloxacin (洛美沙星) | 7.749 | ESI+ | 352.00 | 265.00*, 80.10 | -25, -20 |
16 | chlorpyrifos (毒死蜱) | 7.768 | ESI+ | 351.90 | 265.05*, 37.05 | -30, -39 |
17 | sarafloxacin (沙拉沙星) | 8.048 | ESI+ | 385.90 | 367.95*, 98.90 | -25, -20 |
18 | imidacloprid (吡虫啉) | 8.172 | ESI+ | 256.05 | 175.10*, 09.05 | -17, -14 |
19 | sparfloxacin (司帕沙星) | 8.480 | ESI+ | 393.00 | 349.00*, 92.00 | -40, -20 |
20 | acetamiprid (啶虫脒) | 8.682 | ESI+ | 223.10 | 126.05*, 56.05 | -22, -15 |
21 | gibberellic acid (赤霉素) | 8.744 | ESI- | 345.40 | 143.20*, 39.50 | 32, 16 |
22 | 4-fluorophenoxyacetic acid (4-氟苯氧乙酸) | 8.941 | ESI- | 169.20 | 111.00*, 95.00 | 16, 18 |
23 | chloramphenicol (氯霉素) | 9.144 | ESI- | 340.00 | 152.10*, 57.10 | 17, 11 |
24 | 3-indolylacetic acid (吲哚乙酸) | 9.230 | ESI+ | 176.10 | 129.80*, 03.10 | -18, -16 |
25 | N6-(δ2-isopentenyl)-adenine (异戊烯腺嘌呤) | 9.434 | ESI- | 202.30 | 133.00*, 34.15 | 22, 17 |
26 | 6-benzylaminopurine (6-苄基腺嘌呤) | 9.487 | ESI- | 224.00 | 133.00*, 06.00 | 40, 34 |
27 | 4-chlorophenoxyacetic acid (4-氯苯氧乙酸) | 10.040 | ESI- | 185.00 | 127.10*, 29.00 | 15, 14 |
28 | thidiazuron (噻苯隆) | 10.056 | ESI+ | 240.20 | 102.00*, 28.00 | -16, -17 |
29 | 3-indolebutyric acid (吲哚丁酸) | 10.229 | ESI+ | 204.20 | 186.20*, 29.90 | -10, -28 |
30 | atrazine (莠去津) | 10.556 | ESI+ | 406.10 | 174.05*, 96.05 | -17, -25 |
31 | forchlorfenuron (氯吡脲) | 10.595 | ESI+ | 248.05 | 129.05*, 93.05 | -17, -34 |
32 | metalaxyl-M (精甲霜灵) | 10.614 | ESI+ | 280.10 | 220.15*, 48.10 | -13, -10 |
33 | metalaxyl (甲霜灵) | 10.619 | ESI+ | 280.10 | 220.15*, 92.15 | -13, -18 |
34 | 2,4-dichlorophenoxyacetic acid (2,4-滴) | 10.669 | ESI- | 409.00 | 160.85*, 25.00 | 14, 29 |
35 | azoxystrobin (嘧菌酯) | 10.826 | ESI+ | 404.10 | 372.05*, 29.00 | -14, -31 |
36 | paclobutrazol (多效唑) | 11.064 | ESI+ | 294.10 | 70.05*, 125.05 | -40, -40 |
37 | triazophos (三唑磷) | 11.152 | ESI+ | 314.05 | 162.15*, 19.15 | -19, -35 |
38 | isazophos (氯唑磷) | 11.161 | ESI+ | 314.10 | 162.10*, 20.10 | -16, -27 |
39 | flusilazole (氟硅唑) | 11.394 | ESI+ | 316.10 | 247.10*, 65.10 | -18, -29 |
40 | pyraclostrobin (吡唑醚菌酯) | 11.635 | ESI+ | 388.10 | 194.05*, 63.05 | -30, -32 |
Compound | Linear equation | Linear range/(μg/L) | r2 | LOD/(μg/kg) | LOQ/(μg/kg) |
---|---|---|---|---|---|
Chlormequat | y=1.27×103x-5.36×102 | 2-200 | 0.9966 | 1.5 | 4.5 |
Ronidazole | y=1.82×104x-9.28×103 | 2-200 | 0.9987 | 0.1 | 0.3 |
Metronidazole | y=1.28×104x+4.55×103 | 2-200 | 0.9998 | 0.5 | 1.5 |
Pymetrozine | y=2.98×104x-1.13×105 | 2-200 | 0.9929 | 0.5 | 1.5 |
Dimetridazole | y=3.14×104x-1.22×104 | 2-200 | 0.9997 | 0.2 | 0.6 |
Methomyl | y=1.43×104x-3.36×104 | 2-200 | 0.9914 | 0.2 | 0.6 |
Carbendazim | y=5.18×104x+3.92×104 | 2-200 | 0.9998 | 0.2 | 0.6 |
Enoxacin | y=2.01×104x-1.33×104 | 2-200 | 0.9919 | 1.0 | 3.0 |
Levofloxacin | y=2.07×104x-6.38×104 | 2-200 | 0.9939 | 1.0 | 3.0 |
pefloxacin mesylate | y=1.07×104x-2.77×104 | 2-200 | 0.9959 | 1.0 | 3.0 |
Norfloxacin | y=2.86×104x-1.09×104 | 2-200 | 0.9977 | 0.5 | 1.5 |
Ciprofloxacin | y=1.01×104x+1.21×104 | 2-200 | 0.9939 | 1.0 | 3.0 |
Enrofloxacin | y=1.45×104x-6.98×104 | 2-200 | 0.9932 | 1.0 | 3.0 |
Thiabendazole | y=1.26×104x-1.20×104 | 2-200 | 0.9976 | 0.5 | 1.5 |
Lomefloxacin | y=3.72×104x-1.31×103 | 2-200 | 0.9917 | 0.5 | 1.5 |
Chlorpyrifos | y=2.17×104x-4.32×104 | 2-200 | 0.9903 | 0.5 | 1.5 |
Sarafloxacin | y=2.25×104x-7.64×104 | 2-200 | 0.9953 | 0.5 | 1.5 |
Imidacloprid | y=3.84×103x-1.55×104 | 2-200 | 0.9908 | 1.0 | 3.0 |
Sparfloxacin | y=9.99×103x-4.35×104 | 2-200 | 0.9906 | 0.5 | 1.5 |
Acetamiprid | y=1.18×104x-1.79×104 | 2-200 | 0.9948 | 0.5 | 1.5 |
Gibberellic acid | y=5.95×104x-2.08×103 | 2-200 | 0.9914 | 3.0 | 9.0 |
4-Fluorophenoxyacetic acid | y=6.08×103x-3.00×103 | 2-200 | 0.9989 | 1.5 | 4.5 |
Chloramphenicol | y=8.61×102x+1.86×103 | 2-200 | 0.9970 | 3.0 | 9.0 |
3-Indolylacetic acid | y=7.02×103x+1.76×103 | 2-200 | 0.9961 | 2.0 | 6.0 |
N6-(δ2-Isopentenyl)-adenine | y=3.27×102x-3.65×102 | 2-200 | 0.9967 | 3.0 | 9.0 |
6-Benzylaminopurine | y=3.97×102x-2.74×103 | 2-200 | 0.9945 | 3.0 | 9.0 |
4-Chlorophenoxyacetic acid | y=2.78×103x-2.33×103 | 2-200 | 0.9995 | 3.0 | 9.0 |
Thidiazuron | y=5.69×104x-2.10×104 | 2-200 | 0.9996 | 0.5 | 1.5 |
3-Indolebutyric acid | y=4.55×103x-4.29×103 | 2-200 | 0.9967 | 2.0 | 6.0 |
Atrazine | y=2.23×104x-7.41×104 | 2-200 | 0.9956 | 0.2 | 0.6 |
Compound | Linear equation | Linear range/(μg/L) | r2 | LOD/(μg/kg) | LOQ/(μg/kg) |
Forchlorfenuron | y=1.83×105x-3.65×105 | 2-200 | 0.9977 | 0.1 | 0.3 |
Metalaxyl-M | y=4.74×104x+1.29×105 | 2-200 | 0.9981 | 0.2 | 0.6 |
Metalaxyl | y=2.84×104x+9.92×104 | 2-200 | 0.9966 | 0.2 | 0.6 |
2,4-Dichlorophenoxyacetic acid | y=8.84×103x-3.59×103 | 2-200 | 0.9995 | 2.0 | 6.0 |
Azoxystrobin | y=5.32×104x+1.19×104 | 2-200 | 0.9992 | 0.2 | 0.6 |
Paclobutrazol | y=2.02×105x-3.79×102 | 2-200 | 0.9986 | 0.1 | 0.3 |
Triazophos | y=6.95×104x+1.02×105 | 2-200 | 0.9983 | 0.1 | 0.3 |
Isazophos | y=6.66×104x+1.08×105 | 2-200 | 0.9966 | 0.1 | 0.3 |
Flusilazole | y=3.28×104x-2.57×104 | 2-200 | 0.9994 | 1.0 | 3.0 |
Pyraclostrobin | y=8.67×104x+5.62×105 | 2-200 | 0.9979 | 0.5 | 1.5 |
表 2 40种化合物的线性方程、线性范围、相关系数、检出限和定量限
Table 2 Linear equations, linear ranges, correlation coefficients (r2), LODs and LOQs of the 40 compounds
Compound | Linear equation | Linear range/(μg/L) | r2 | LOD/(μg/kg) | LOQ/(μg/kg) |
---|---|---|---|---|---|
Chlormequat | y=1.27×103x-5.36×102 | 2-200 | 0.9966 | 1.5 | 4.5 |
Ronidazole | y=1.82×104x-9.28×103 | 2-200 | 0.9987 | 0.1 | 0.3 |
Metronidazole | y=1.28×104x+4.55×103 | 2-200 | 0.9998 | 0.5 | 1.5 |
Pymetrozine | y=2.98×104x-1.13×105 | 2-200 | 0.9929 | 0.5 | 1.5 |
Dimetridazole | y=3.14×104x-1.22×104 | 2-200 | 0.9997 | 0.2 | 0.6 |
Methomyl | y=1.43×104x-3.36×104 | 2-200 | 0.9914 | 0.2 | 0.6 |
Carbendazim | y=5.18×104x+3.92×104 | 2-200 | 0.9998 | 0.2 | 0.6 |
Enoxacin | y=2.01×104x-1.33×104 | 2-200 | 0.9919 | 1.0 | 3.0 |
Levofloxacin | y=2.07×104x-6.38×104 | 2-200 | 0.9939 | 1.0 | 3.0 |
pefloxacin mesylate | y=1.07×104x-2.77×104 | 2-200 | 0.9959 | 1.0 | 3.0 |
Norfloxacin | y=2.86×104x-1.09×104 | 2-200 | 0.9977 | 0.5 | 1.5 |
Ciprofloxacin | y=1.01×104x+1.21×104 | 2-200 | 0.9939 | 1.0 | 3.0 |
Enrofloxacin | y=1.45×104x-6.98×104 | 2-200 | 0.9932 | 1.0 | 3.0 |
Thiabendazole | y=1.26×104x-1.20×104 | 2-200 | 0.9976 | 0.5 | 1.5 |
Lomefloxacin | y=3.72×104x-1.31×103 | 2-200 | 0.9917 | 0.5 | 1.5 |
Chlorpyrifos | y=2.17×104x-4.32×104 | 2-200 | 0.9903 | 0.5 | 1.5 |
Sarafloxacin | y=2.25×104x-7.64×104 | 2-200 | 0.9953 | 0.5 | 1.5 |
Imidacloprid | y=3.84×103x-1.55×104 | 2-200 | 0.9908 | 1.0 | 3.0 |
Sparfloxacin | y=9.99×103x-4.35×104 | 2-200 | 0.9906 | 0.5 | 1.5 |
Acetamiprid | y=1.18×104x-1.79×104 | 2-200 | 0.9948 | 0.5 | 1.5 |
Gibberellic acid | y=5.95×104x-2.08×103 | 2-200 | 0.9914 | 3.0 | 9.0 |
4-Fluorophenoxyacetic acid | y=6.08×103x-3.00×103 | 2-200 | 0.9989 | 1.5 | 4.5 |
Chloramphenicol | y=8.61×102x+1.86×103 | 2-200 | 0.9970 | 3.0 | 9.0 |
3-Indolylacetic acid | y=7.02×103x+1.76×103 | 2-200 | 0.9961 | 2.0 | 6.0 |
N6-(δ2-Isopentenyl)-adenine | y=3.27×102x-3.65×102 | 2-200 | 0.9967 | 3.0 | 9.0 |
6-Benzylaminopurine | y=3.97×102x-2.74×103 | 2-200 | 0.9945 | 3.0 | 9.0 |
4-Chlorophenoxyacetic acid | y=2.78×103x-2.33×103 | 2-200 | 0.9995 | 3.0 | 9.0 |
Thidiazuron | y=5.69×104x-2.10×104 | 2-200 | 0.9996 | 0.5 | 1.5 |
3-Indolebutyric acid | y=4.55×103x-4.29×103 | 2-200 | 0.9967 | 2.0 | 6.0 |
Atrazine | y=2.23×104x-7.41×104 | 2-200 | 0.9956 | 0.2 | 0.6 |
Compound | Linear equation | Linear range/(μg/L) | r2 | LOD/(μg/kg) | LOQ/(μg/kg) |
Forchlorfenuron | y=1.83×105x-3.65×105 | 2-200 | 0.9977 | 0.1 | 0.3 |
Metalaxyl-M | y=4.74×104x+1.29×105 | 2-200 | 0.9981 | 0.2 | 0.6 |
Metalaxyl | y=2.84×104x+9.92×104 | 2-200 | 0.9966 | 0.2 | 0.6 |
2,4-Dichlorophenoxyacetic acid | y=8.84×103x-3.59×103 | 2-200 | 0.9995 | 2.0 | 6.0 |
Azoxystrobin | y=5.32×104x+1.19×104 | 2-200 | 0.9992 | 0.2 | 0.6 |
Paclobutrazol | y=2.02×105x-3.79×102 | 2-200 | 0.9986 | 0.1 | 0.3 |
Triazophos | y=6.95×104x+1.02×105 | 2-200 | 0.9983 | 0.1 | 0.3 |
Isazophos | y=6.66×104x+1.08×105 | 2-200 | 0.9966 | 0.1 | 0.3 |
Flusilazole | y=3.28×104x-2.57×104 | 2-200 | 0.9994 | 1.0 | 3.0 |
Pyraclostrobin | y=8.67×104x+5.62×105 | 2-200 | 0.9979 | 0.5 | 1.5 |
Compound | 5 μg/kg | 10 μg/kg | 50 μg/kg | |||||
---|---|---|---|---|---|---|---|---|
Recovery/% | RSD/% | Recovery/% | RSD/% | Recovery/% | RSD/% | |||
Chlormequat | 83.4 | 6.9 | 86.1 | 5.2 | 93.6 | 2.8 | ||
Ronidazole | 111.2 | 4.3 | 93.2 | 2.4 | 96.2 | 3.7 | ||
Metronidazole | 88.2 | 5.3 | 85.7 | 6.5 | 91.0 | 5.7 | ||
Pymetrozine | 102.4 | 6.9 | 82.1 | 5.1 | 84.5 | 6.5 | ||
Dimetridazole | 108.4 | 2.1 | 89.6 | 3.9 | 92.6 | 2.2 | ||
Methomyl | 82.7 | 8.7 | 89.4 | 4.9 | 85.4 | 5.1 | ||
Carbendazim | 84.3 | 7.5 | 97.6 | 4.7 | 94.1 | 8.0 | ||
Enoxacin | 82.6 | 1.8 | 95.6 | 3.0 | 101.7 | 4.5 | ||
Levofloxacin | 102.1 | 7.6 | 106.5 | 7.1 | 93.0 | 5.4 | ||
pefloxacin mesylate | 90.3 | 7.1 | 101.5 | 5.9 | 92.8 | 4.1 | ||
Norfloxacin | 84.2 | 5.9 | 86.7 | 4.6 | 88.6 | 4.7 | ||
Ciprofloxacin | 99.5 | 8.3 | 102.2 | 7.2 | 96.4 | 4.3 | ||
Enrofloxacin | 104.7 | 5.3 | 100.9 | 4.2 | 101.6 | 3.8 | ||
Thiabendazole | 85.4 | 9.0 | 82.9 | 6.3 | 82.6 | 4.4 | ||
Lomefloxacin | 97.9 | 6.2 | 105.5 | 6.1 | 99.2 | 2.9 | ||
Chlorpyrifos | 112.6 | 9.7 | 113.1 | 6.3 | 107.4 | 4.1 | ||
Sarafloxacin | 108.4 | 4.4 | 105.2 | 3.9 | 102.6 | 3.7 | ||
Imidacloprid | 80.0 | 7.6 | 84.4 | 6.2 | 85.1 | 5.9 | ||
Sparfloxacin | 106.6 | 5.3 | 98.4 | 3.6 | 102.5 | 5.4 | ||
Acetamiprid | 105.3 | 3.8 | 111.6 | 3.2 | 115.3 | 4.2 | ||
Gibberellic acid | 77.4 | 8.2 | 81.6 | 1.7 | 82.1 | 5.7 | ||
4-Fluorophenoxyacetic acid | 98.6 | 7.2 | 93.6 | 4.8 | 91.9 | 3.3 | ||
Chloramphenicol | 78.8 | 4.0 | 85.8 | 5.1 | 85.4 | 5.9 | ||
3-Indolylacetic acid | 89.9 | 3.1 | 86.5 | 3.4 | 97.7 | 6.3 | ||
N6-(δ2-Isopentenyl)-adenine | 92.3 | 1.6 | 87.2 | 6.2 | 96.8 | 4.0 | ||
6-Benzylaminopurine | 102.4 | 6.4 | 94.3 | 5.9 | 95.6 | 5.2 | ||
4-Chlorophenoxyacetic acid | 111.3 | 8.9 | 108.4 | 5.3 | 106.8 | 5.7 | ||
Thidiazuron | 94.7 | 1.9 | 95.5 | 4.6 | 92.7 | 2.4 | ||
3-Indolebutyric acid | 78.5 | 6.2 | 90.3 | 3.6 | 86.4 | 3.5 | ||
Atrazine | 94.6 | 3.8 | 89.0 | 6.4 | 86.9 | 4.6 | ||
Compound | 5 μg/kg | 10 μg/kg | 50 μg/kg | |||||
Recovery/% | RSD/% | Recovery/% | RSD/% | Recovery/% | RSD/% | |||
Forchlorfenuron | 103.4 | 5.3 | 108.2 | 4.2 | 105.7 | 2.7 | ||
Metalaxyl-M | 112.4 | 4.7 | 98.8 | 2.7 | 106.4 | 4.6 | ||
Metalaxyl | 97.4 | 3.0 | 108.5 | 1.7 | 102.1 | 3.2 | ||
2,4-Dichlorophenoxyacetic acid | 85.5 | 8.3 | 83.2 | 8.0 | 87.5 | 6.6 | ||
Azoxystrobin | 91.6 | 3.4 | 87.3 | 5.7 | 84.2 | 5.9 | ||
Paclobutrazol | 112.6 | 2.2 | 103.5 | 6.1 | 107.6 | 3.6 | ||
Triazophos | 82.1 | 9.1 | 84.3 | 7.4 | 88.6 | 5.5 | ||
Isazophos | 91.6 | 5.5 | 83.6 | 3.8 | 84.3 | 1.9 | ||
Flusilazole | 82.1 | 2.1 | 88.3 | 4.4 | 85.7 | 1.3 | ||
Pyraclostrobin | 116.4 | 5.9 | 107.2 | 4.6 | 108.7 | 4.8 |
表 3 40种化合物的回收率和精密度(n=6)
Table 3 Recoveries and precisions of the 40 compounds (n=6)
Compound | 5 μg/kg | 10 μg/kg | 50 μg/kg | |||||
---|---|---|---|---|---|---|---|---|
Recovery/% | RSD/% | Recovery/% | RSD/% | Recovery/% | RSD/% | |||
Chlormequat | 83.4 | 6.9 | 86.1 | 5.2 | 93.6 | 2.8 | ||
Ronidazole | 111.2 | 4.3 | 93.2 | 2.4 | 96.2 | 3.7 | ||
Metronidazole | 88.2 | 5.3 | 85.7 | 6.5 | 91.0 | 5.7 | ||
Pymetrozine | 102.4 | 6.9 | 82.1 | 5.1 | 84.5 | 6.5 | ||
Dimetridazole | 108.4 | 2.1 | 89.6 | 3.9 | 92.6 | 2.2 | ||
Methomyl | 82.7 | 8.7 | 89.4 | 4.9 | 85.4 | 5.1 | ||
Carbendazim | 84.3 | 7.5 | 97.6 | 4.7 | 94.1 | 8.0 | ||
Enoxacin | 82.6 | 1.8 | 95.6 | 3.0 | 101.7 | 4.5 | ||
Levofloxacin | 102.1 | 7.6 | 106.5 | 7.1 | 93.0 | 5.4 | ||
pefloxacin mesylate | 90.3 | 7.1 | 101.5 | 5.9 | 92.8 | 4.1 | ||
Norfloxacin | 84.2 | 5.9 | 86.7 | 4.6 | 88.6 | 4.7 | ||
Ciprofloxacin | 99.5 | 8.3 | 102.2 | 7.2 | 96.4 | 4.3 | ||
Enrofloxacin | 104.7 | 5.3 | 100.9 | 4.2 | 101.6 | 3.8 | ||
Thiabendazole | 85.4 | 9.0 | 82.9 | 6.3 | 82.6 | 4.4 | ||
Lomefloxacin | 97.9 | 6.2 | 105.5 | 6.1 | 99.2 | 2.9 | ||
Chlorpyrifos | 112.6 | 9.7 | 113.1 | 6.3 | 107.4 | 4.1 | ||
Sarafloxacin | 108.4 | 4.4 | 105.2 | 3.9 | 102.6 | 3.7 | ||
Imidacloprid | 80.0 | 7.6 | 84.4 | 6.2 | 85.1 | 5.9 | ||
Sparfloxacin | 106.6 | 5.3 | 98.4 | 3.6 | 102.5 | 5.4 | ||
Acetamiprid | 105.3 | 3.8 | 111.6 | 3.2 | 115.3 | 4.2 | ||
Gibberellic acid | 77.4 | 8.2 | 81.6 | 1.7 | 82.1 | 5.7 | ||
4-Fluorophenoxyacetic acid | 98.6 | 7.2 | 93.6 | 4.8 | 91.9 | 3.3 | ||
Chloramphenicol | 78.8 | 4.0 | 85.8 | 5.1 | 85.4 | 5.9 | ||
3-Indolylacetic acid | 89.9 | 3.1 | 86.5 | 3.4 | 97.7 | 6.3 | ||
N6-(δ2-Isopentenyl)-adenine | 92.3 | 1.6 | 87.2 | 6.2 | 96.8 | 4.0 | ||
6-Benzylaminopurine | 102.4 | 6.4 | 94.3 | 5.9 | 95.6 | 5.2 | ||
4-Chlorophenoxyacetic acid | 111.3 | 8.9 | 108.4 | 5.3 | 106.8 | 5.7 | ||
Thidiazuron | 94.7 | 1.9 | 95.5 | 4.6 | 92.7 | 2.4 | ||
3-Indolebutyric acid | 78.5 | 6.2 | 90.3 | 3.6 | 86.4 | 3.5 | ||
Atrazine | 94.6 | 3.8 | 89.0 | 6.4 | 86.9 | 4.6 | ||
Compound | 5 μg/kg | 10 μg/kg | 50 μg/kg | |||||
Recovery/% | RSD/% | Recovery/% | RSD/% | Recovery/% | RSD/% | |||
Forchlorfenuron | 103.4 | 5.3 | 108.2 | 4.2 | 105.7 | 2.7 | ||
Metalaxyl-M | 112.4 | 4.7 | 98.8 | 2.7 | 106.4 | 4.6 | ||
Metalaxyl | 97.4 | 3.0 | 108.5 | 1.7 | 102.1 | 3.2 | ||
2,4-Dichlorophenoxyacetic acid | 85.5 | 8.3 | 83.2 | 8.0 | 87.5 | 6.6 | ||
Azoxystrobin | 91.6 | 3.4 | 87.3 | 5.7 | 84.2 | 5.9 | ||
Paclobutrazol | 112.6 | 2.2 | 103.5 | 6.1 | 107.6 | 3.6 | ||
Triazophos | 82.1 | 9.1 | 84.3 | 7.4 | 88.6 | 5.5 | ||
Isazophos | 91.6 | 5.5 | 83.6 | 3.8 | 84.3 | 1.9 | ||
Flusilazole | 82.1 | 2.1 | 88.3 | 4.4 | 85.7 | 1.3 | ||
Pyraclostrobin | 116.4 | 5.9 | 107.2 | 4.6 | 108.7 | 4.8 |
Compound | Contents/(μg/kg) | |
---|---|---|
This method | Standard method | |
4-Chlorophenoxyacetic acid | 37.5-52.4 | 34.2-343.5 |
6-Benzylaminopurine | 32.4-273.1 | 29.3-279.4 |
Carbendazim | 28.8-38.7 | - |
2,4-Dichlorophenoxyacetic acid | 16.1-20.2 | 14.1-18.3 |
Gibberellic acid | 19.9 | 22.1 |
Enrofloxacin | 13.6 | 15.3 |
表 4 实际样品检测结果
Table 4 Test results of real samples
Compound | Contents/(μg/kg) | |
---|---|---|
This method | Standard method | |
4-Chlorophenoxyacetic acid | 37.5-52.4 | 34.2-343.5 |
6-Benzylaminopurine | 32.4-273.1 | 29.3-279.4 |
Carbendazim | 28.8-38.7 | - |
2,4-Dichlorophenoxyacetic acid | 16.1-20.2 | 14.1-18.3 |
Gibberellic acid | 19.9 | 22.1 |
Enrofloxacin | 13.6 | 15.3 |
Compound | LODs/(μg/kg) | |
---|---|---|
Reference | This work | |
Chlormequat | 5[ | 0.2 |
Carbendazim | 45[ | 0.2 |
Ronidazole | 0.4[ | 0.1 |
Dimethylnidazole | 0.5[ | 0.2 |
Carbendazim | 3.7[ | 0.2 |
Enoxacin | 2[ | 1.0 |
Levofloxacin | 2[ | 1.0 |
pefloxacin mesylate | 2[ | 1.0 |
Norfloxacin | 64[ | 0.5 |
Ciprofloxacin | 2[ | 1.0 |
Enrofloxacin | 2[ | 1.0 |
Thiabendazole | 2.1[ | 0.5 |
Lomefloxacin | 2[ | 0.5 |
Sarafloxacin | 2[ | 0.5 |
Sparfloxacin | 2[ | 0.5 |
Gibberellic acid | 6.0[ | 3.0 |
4-Fluorophenoxyacetic acid | 10[ | 1.5 |
Chloramphenicol | 10[ | 2.0 |
3-Indolylacetic acid | 72[ | 3.0 |
N6-(δ2-Isopentenyl)-adenine | 10[ | 3.0 |
6-Benzylaminopurine | 3.8[ | 3.0 |
4-Chlorophenoxyacetic acid | 5[ | 3.0 |
Thidiazuron | 10[ | 0.2 |
3-Indolebutyric acid | 10[ | 2.0 |
Atrazine | 1[ | 0.2 |
Forchlorfenuron | 0.26[ | 0.1 |
2,4-Dichlorophenoxyacetic acid | 1[ | 2.0 |
Paclobutrazol | 0.6[ | 0.1 |
表 5 本方法与文献方法的比较
Table 5 Comparison of the proposed method with references
Compound | LODs/(μg/kg) | |
---|---|---|
Reference | This work | |
Chlormequat | 5[ | 0.2 |
Carbendazim | 45[ | 0.2 |
Ronidazole | 0.4[ | 0.1 |
Dimethylnidazole | 0.5[ | 0.2 |
Carbendazim | 3.7[ | 0.2 |
Enoxacin | 2[ | 1.0 |
Levofloxacin | 2[ | 1.0 |
pefloxacin mesylate | 2[ | 1.0 |
Norfloxacin | 64[ | 0.5 |
Ciprofloxacin | 2[ | 1.0 |
Enrofloxacin | 2[ | 1.0 |
Thiabendazole | 2.1[ | 0.5 |
Lomefloxacin | 2[ | 0.5 |
Sarafloxacin | 2[ | 0.5 |
Sparfloxacin | 2[ | 0.5 |
Gibberellic acid | 6.0[ | 3.0 |
4-Fluorophenoxyacetic acid | 10[ | 1.5 |
Chloramphenicol | 10[ | 2.0 |
3-Indolylacetic acid | 72[ | 3.0 |
N6-(δ2-Isopentenyl)-adenine | 10[ | 3.0 |
6-Benzylaminopurine | 3.8[ | 3.0 |
4-Chlorophenoxyacetic acid | 5[ | 3.0 |
Thidiazuron | 10[ | 0.2 |
3-Indolebutyric acid | 10[ | 2.0 |
Atrazine | 1[ | 0.2 |
Forchlorfenuron | 0.26[ | 0.1 |
2,4-Dichlorophenoxyacetic acid | 1[ | 2.0 |
Paclobutrazol | 0.6[ | 0.1 |
|
[1] | 赵芮, 黄晴雯, 余智颖, 韩铮, 范楷, 赵志辉, 聂冬霞. QuEChERS-超高效液相色谱-串联质谱法同时测定水果中36种真菌毒素[J]. 色谱, 2023, 41(9): 760-770. |
[2] | 岳超, 赵超群, 毛思浩, 王展华, 施贝, 徐欣丰, 梁晶晶. 通过式固相萃取净化-超高效液相色谱-串联质谱法测定液体乳中10种氨基甲酸酯类农药残留[J]. 色谱, 2023, 41(9): 807-813. |
[3] | 吴萍萍, 林仁义, 黄丽英. 三相中空纤维液相微萃取-高效液相色谱法测定铁皮石斛和金线莲中3种植物生长调节剂[J]. 色谱, 2023, 41(8): 683-689. |
[4] | 孟二琼, 念琪循, 李峰, 张秋萍, 许茜, 王春民. 磺酸化磁性氮化碳固相萃取-超高液相色谱-串联质谱筛检淡水鱼中孔雀石绿和隐色孔雀石绿[J]. 色谱, 2023, 41(8): 673-682. |
[5] | 王秋旭, 冯启言, 朱雪强. 加速溶剂萃取-固相萃取净化结合超高效液相色谱-串联质谱法测定沉积物中双酚类化合物[J]. 色谱, 2023, 41(7): 582-590. |
[6] | 李洁, 鞠香, 王艳丽, 田其燕, 梁秀清, 李海霞, 刘艳明. QuEChERS-在线凝胶渗透色谱-气相色谱-串联质谱法高通量筛查动物源性食品中的多农药残留[J]. 色谱, 2023, 41(7): 610-621. |
[7] | 夏宝林, 汪仕韬, 殷晶晶, 张维益, 杨娜, 刘强, 吴海晶. 自动上样固相萃取-超高效液相色谱-串联质谱法同时测定水中9类43种抗菌药物残留[J]. 色谱, 2023, 41(7): 591-601. |
[8] | 陈东洋, 张昊, 张磊, 王一红, 王小丹, 冯家力, 梁静, 钟旋. 固相萃取-超高效液相色谱-串联质谱法测定发酵食品中的曲酸[J]. 色谱, 2023, 41(7): 632-639. |
[9] | 童学智, 陈东洋, 冯家力, 范翔, 张昊, 杨胜园. QuEChERS-超高效液相色谱-串联质谱法快速测定水产品中5种卤代苯醌[J]. 色谱, 2023, 41(6): 490-496. |
[10] | 孙佳林, 牛宇敏, 高群, 张晶, 邵兵. 超高效液相色谱-串联质谱法测定灰尘中26种双酚类化合物[J]. 色谱, 2023, 41(5): 417-425. |
[11] | 邵曼, 余晓琴, 黄丽娟, 姚欢, 李澍才. 增强型脂质去除净化剂结合超高效液相色谱-串联质谱法测定食品中8种大麻素类化合物[J]. 色谱, 2023, 41(5): 426-433. |
[12] | 李振环, 胡小键, 陆一夫, 谢琳娜, 朱英. 基于高通量全自动固相萃取的超高效液相色谱-串联质谱法测定人尿中16种抗生素和4种β-受体激动剂[J]. 色谱, 2023, 41(5): 397-408. |
[13] | 吴少明, 欧阳立群, 孟鹏, 何孟杭, 林钦, 陈言凯, 刘文菁, 苏晓明, 戴明. 固相萃取净化-超高效液相色谱-串联质谱法测定畜肉中18种卡因类麻醉剂[J]. 色谱, 2023, 41(5): 434-442. |
[14] | 曾永福, 陈美芳, 邵雨, 闫永欢, 张海超, 王敬, 艾连峰, 康维钧. 植物中27种典型药品及个人护理品多残留检测方法的建立及其在芽苗菜中迁移规律的分析[J]. 色谱, 2023, 41(5): 386-396. |
[15] | 朱卫红, 王超, 张霖琳, 袁懋. 超高效液相色谱-串联质谱法直接测定水中5种黄原酸[J]. 色谱, 2023, 41(4): 339-347. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||